New therapeutic strategies in advanced stage breast and tubo-ovarian cancers

New targeted therapies modify therapeutic strategies for advanced stage breast and tubo-ovarian cancers. Chemotherapy and endocrine therapy remain the cornerstones of breast cancer treatment. Inhibitors of CDK4/6, mTOR and PI3K are associated with endocrine therapy to increase its effectiveness. PAR...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revue médicale suisse 2019-05, Vol.15 (651), p.1027-1031
Hauptverfasser:	Nikolopoulou, Asteria, Galli-Vareia, Ilianna, Stravodimou, Athina, Sarivalasis, Apostolos, Zaman, Khalil
Format:	Artikel
Sprache:	fre
Schlagworte:	Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - genetics Breast Neoplasms - therapy Female Genes, BRCA1 Genes, BRCA2 Humans Ovarian Neoplasms - genetics Ovarian Neoplasms - therapy Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!